AVXL
Price
$8.19
Change
+$0.41 (+5.27%)
Updated
Jun 6, 04:11 PM (EDT)
Capitalization
663.34M
67 days until earnings call
DRMA
Price
$0.73
Change
+$0.03 (+4.23%)
Updated
Jun 6, 04:14 PM (EDT)
Capitalization
4.49M
Interact to see
Advertisement

AVXL vs DRMA

Header iconAVXL vs DRMA Comparison
Open Charts AVXL vs DRMABanner chart's image
Anavex Life Sciences
Price$8.19
Change+$0.41 (+5.27%)
Volume$1.19K
Capitalization663.34M
Dermata Therapeutics
Price$0.73
Change+$0.03 (+4.23%)
Volume$242
Capitalization4.49M
AVXL vs DRMA Comparison Chart
Loading...
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DRMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVXL vs. DRMA commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVXL is a StrongBuy and DRMA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (AVXL: $7.77 vs. DRMA: $0.70)
Brand notoriety: AVXL and DRMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVXL: 61% vs. DRMA: 87%
Market capitalization -- AVXL: $663.34M vs. DRMA: $4.49M
AVXL [@Biotechnology] is valued at $663.34M. DRMA’s [@Biotechnology] market capitalization is $4.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVXL’s FA Score shows that 0 FA rating(s) are green whileDRMA’s FA Score has 1 green FA rating(s).

  • AVXL’s FA Score: 0 green, 5 red.
  • DRMA’s FA Score: 1 green, 4 red.
According to our system of comparison, DRMA is a better buy in the long-term than AVXL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVXL’s TA Score shows that 4 TA indicator(s) are bullish while DRMA’s TA Score has 3 bullish TA indicator(s).

  • AVXL’s TA Score: 4 bullish, 5 bearish.
  • DRMA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AVXL is a better buy in the short-term than DRMA.

Price Growth

AVXL (@Biotechnology) experienced а +1.83% price change this week, while DRMA (@Biotechnology) price change was -3.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.55%. For the same industry, the average monthly price growth was +17.24%, and the average quarterly price growth was +3.49%.

Reported Earning Dates

AVXL is expected to report earnings on Aug 12, 2025.

DRMA is expected to report earnings on Mar 17, 2025.

Industries' Descriptions

@Biotechnology (+11.55% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVXL($663M) has a higher market cap than DRMA($4.49M). AVXL YTD gains are higher at: -27.654 vs. DRMA (-47.852). DRMA has higher annual earnings (EBITDA): -11.53M vs. AVXL (-45.2M). AVXL has more cash in the bank: 121M vs. DRMA (6.14M). AVXL has less debt than DRMA: AVXL (88.2K) vs DRMA (175K). AVXL (0) and DRMA (0) have equivalent revenues.
AVXLDRMAAVXL / DRMA
Capitalization663M4.49M14,766%
EBITDA-45.2M-11.53M392%
Gain YTD-27.654-47.85258%
P/E RatioN/AN/A-
Revenue00-
Total Cash121M6.14M1,969%
Total Debt88.2K175K50%
FUNDAMENTALS RATINGS
AVXL: Fundamental Ratings
AVXL
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
82
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVXLDRMA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 11 days ago
81%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DRMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HTHT35.810.42
+1.19%
H World Group Limited
JWEL1.95N/A
-0.23%
Jowell Global Ltd
SPB55.96-0.28
-0.50%
Spectrum Brands Holdings
EWCZ5.57-0.14
-2.37%
European Wax Center
AIXI2.87-0.13
-4.33%
XIAO-I Corporation

AVXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVXL has been loosely correlated with PLRX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if AVXL jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVXL
1D Price
Change %
AVXL100%
+0.65%
PLRX - AVXL
48%
Loosely correlated
-2.71%
TENX - AVXL
47%
Loosely correlated
+0.34%
AXON - AVXL
45%
Loosely correlated
+1.08%
RXRX - AVXL
45%
Loosely correlated
-7.13%
IDYA - AVXL
42%
Loosely correlated
-0.09%
More

DRMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, DRMA has been loosely correlated with IRON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if DRMA jumps, then IRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRMA
1D Price
Change %
DRMA100%
-0.56%
IRON - DRMA
43%
Loosely correlated
+1.39%
PVLA - DRMA
36%
Loosely correlated
-1.34%
KANT - DRMA
28%
Poorly correlated
-1.81%
KRRO - DRMA
28%
Poorly correlated
+3.96%
AVXL - DRMA
27%
Poorly correlated
+0.65%
More